biliary stricture
Conditions
Interventions
Ursodeoxycholic acid:Ursodeoxycholic acid 13-15mg/kg, 1-2 times daily, treatment time is given for more than12 moths
The control group:Do not give anything
Sponsors
Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who were diagnosed as common biliary stricture with preoperative imaging and should undergo long-term biliary drainage, and were treated with ERCP placing a plastic stent or plastic stents, and were treated voluntarily with ursodeoxycholic acid were enrolled in this study.
Exclusion criteria
Exclusion criteria: 1. Patients under 18 years old or without autonomy; 2. Patients for whom ERCP were not suitable. 3. Patients accompanied by basic diseases associated with heart, lung and liver. 4. patients with malignant tumors, except for biliary tumors; 5. patients who have been treated with PTCD; 6. pregnant or lactating patients; 7. Patients known to suffer from side effects associated with ursodeoxycholic acid or had been treated with ursodeoxycholic acid regularly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bilirubin;Total bile acid;phospholipid;Lecithin;Bile salt;Cholesterol; | — |
Secondary
| Measure | Time frame |
|---|---|
| calcium ion;ß-glucosidas; | — |
Countries
China
Contacts
Public ContactXu Jianming
Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed